Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 371

1.

Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex.

Roenker NL, Gudelsky GA, Ahlbrand R, Horn PS, Richtand NM.

Neuropharmacology. 2012 Sep;63(4):575-81. doi: 10.1016/j.neuropharm.2012.04.032. Epub 2012 May 9.

2.

Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.

Roenker NL, Gudelsky G, Ahlbrand R, Bronson SL, Kern JR, Waterman H, Richtand NM.

Neurosci Lett. 2011 Aug 18;500(3):167-71. doi: 10.1016/j.neulet.2011.06.011. Epub 2011 Jun 15.

3.

Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide.

Fejgin K, Pålsson E, Wass C, Finnerty N, Lowry J, Klamer D.

Neuropsychopharmacology. 2009 Jun;34(7):1673-84. doi: 10.1038/npp.2008.225. Epub 2009 Jan 14.

5.

Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.

López-Gil X, Babot Z, Amargós-Bosch M, Suñol C, Artigas F, Adell A.

Neuropsychopharmacology. 2007 Oct;32(10):2087-97. Epub 2007 Mar 14.

6.

Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex.

Xi D, Li YC, Snyder MA, Gao RY, Adelman AE, Zhang W, Shumsky JS, Gao WJ.

Neuropsychopharmacology. 2011 May;36(6):1260-74. doi: 10.1038/npp.2011.12. Epub 2011 Feb 16. Erratum in: Neuropsychopharmacology. 2013 May;38(6):1141.

7.

Effects of various nitric oxide synthase inhibitors on NMDA-induced neuronal injury in rat cortical neurons.

Wang JY, Chi SI, Wang JY, Hwang CP, Wang JY.

Chin J Physiol. 1996;39(4):227-33.

PMID:
9058007
8.

Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.

López-Gil X, Artigas F, Adell A.

Int J Neuropsychopharmacol. 2009 May;12(4):487-99. doi: 10.1017/S1461145708009267. Epub 2008 Aug 28.

PMID:
18752722
9.

Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.

Shim I, Kim HT, Kim YH, Chun BG, Hahm DH, Lee EH, Kim SE, Lee HJ.

Eur J Pharmacol. 2002 May 17;443(1-3):119-24.

PMID:
12044801
10.
11.
12.

Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.

Campos F, Alfonso M, Vidal L, Faro LR, Durán R.

Eur J Pharmacol. 2006 Oct 24;548(1-3):90-8. Epub 2006 Jul 27.

PMID:
16963020
13.

GABA(A), but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex.

Pepicelli O, Brescia A, Gherzi E, Raiteri M, Fedele E.

Neuropharmacology. 2004 Mar;46(4):480-9.

PMID:
14975671
14.
15.

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.

Yonezawa Y, Kuroki T, Kawahara T, Tashiro N, Uchimura H.

Eur J Pharmacol. 1998 Jan 2;341(1):45-56.

PMID:
9489855
17.

Immobilization-induced glutamate efflux in medial prefrontal cortex: blockade by (+)-Mk-801, a selective NMDA receptor antagonist.

Steciuk M, Kram M, Kramer GL, Petty F.

Stress. 2000 May;3(3):195-9. No abstract available.

PMID:
10938580
18.

NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus.

Nei K, Matsuyama S, Shuntoh H, Tanaka C.

Brain Res. 1996 Jul 22;728(1):105-10.

PMID:
8864303
19.

Involvement of nitric oxide synthase and ROS-mediated activation of L-type voltage-gated Ca2+ channels in NMDA-induced DPYSL3 degradation.

Kowara R, Moraleja KL, Chakravarthy B.

Brain Res. 2006 Nov 13;1119(1):40-9. Epub 2006 Sep 20.

PMID:
16987501
20.

Reciprocal regulation of nitric oxide and glutamate in the nucleus tractus solitarii of rats.

Lin HC, Kang BH, Wan FJ, Huang ST, Tseng CJ.

Eur J Pharmacol. 2000 Oct 27;407(1-2):83-9.

PMID:
11050294

Supplemental Content

Support Center